SEP 9, 2026 · JOURNAL ARTICLE
Tumor genomic alterations and their exploratory association with treatment response in recurrent head and neck cancer patients
Scientific Reports
Single-center retrospective analysis of 86 patients with exploratory, hypothesis-generating associations between genomic alterations and clinical outcomes; the authors explicitly state prospective validation in larger cohorts is necessary before clinical application.
Reported
TP53 mutation prevalence55%
TP53 and OS hazard ratio1.77
TP53 and OS p-value0.033